Chronic Total Occlusion Market to Surge with Demand for Advanced, High-Precision Interventional Devices Valued at US$2.44 billion in 2024. The market is projected to reach US$4.22 billion by 2031, ...
NEW YORK, Sept. 23, 2025 /PRNewswire/ -- A new in-depth report by The Insight Partners highlights chronic total occlusion market growth, driven by Rising Prevalence of Cardiovascular Diseases (CVDs).
Caranx Medical ("Caranx", a CarvOlix group company), a French medical device company specializing in the development of an autonomous robot to democratize access to Transcatheter Aortic Valve ...
Remedy Robotics announced that it debuted the N1 system, a remotely operable endovascular surgical robotic system.
Under Nasdaq rules, if a stock stays under $1 for 30 consecutive trading days, delisting procedures may begin ... Bae Jeong-nam mourns dog Bell after cardiac arrest during drama filming Review: This ...
A pioneering procedure is showcasing the future of medicine. UC Health performed the region's first fully robotic heart ...
A team of surgeons performed a world-first operation that could change the way heart failure patients are treated.
Dr. Antonio Polanco, a cardiothoracic surgeon at Cleveland Clinic, discusses emerging technologies that make ...
Every year, more than 12,000 Australians undergo open heart surgery—an hours-long medical procedure during which surgeons go ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback